​

Cidara Therapeutics Ownership | Who Owns Cidara Therapeutics?

OverviewForecastFinancialsChartTranscripts

Cidara Therapeutics Ownership Summary

Cidara Therapeutics is owned by 55.84% institutional investors, 0.46% insiders, and 43.70% retail investors. Ra capital management is the largest institutional shareholder, holding 21.65% of CDTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.55% of its assets in Cidara Therapeutics shares.

CDTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCidara Therapeutics55.84%0.46%43.70%
SectorHealthcare Stocks 232.63%10.66%-143.29%
IndustryBiotech Stocks 382.12%10.42%-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management3.37M21.65%$322.28M
Bain capital life sciences investors3.02M19.43%$289.29M
Vanguard group2.01M12.91%$443.37M
Blackrock funding, inc. /de1.68M10.81%$371.24M
Point72 asset management1.58M10.15%$151.12M
Bvf inc/il1.41M9.10%$135.42M
Vivo capital1.31M8.44%$125.58M
Ubs group1.07M6.91%$237.44M
Darwin global management997.20K6.41%$94.99M
Paradigm biocapital advisors lp961.16K6.18%$92.04M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bain capital life sciences investors3.02M19.20%$289.29M
Acuta capital partners141.53K14.01%$13.55M
Vivo capital1.31M10.11%$125.58M
Velan capital investment management lp108.40K9.75%$10.38M
Fny investment advisers145.53K9.07%$32.15M
Ubs oconnor315.47K8.12%$69.69M
Cibra capital18.71K7.10%$4.13B
Superstring capital management lp68.46K6.46%$6.56M
Chicago capital management49.00K5.56%$8.17M
Bvf inc/il1.41M5.49%$135.42M

Top Buyers

HolderShares% AssetsChange
Paradigm biocapital advisors lp961.16K2.62%961.16K
Vanguard group2.01M0.01%776.53K
Fmr775.53K0.00%666.82K
Bvf inc/il1.41M5.49%627.77K
Ubs group1.07M0.04%601.37K

Top Sellers

HolderShares% AssetsChange
5am venture management---1.13M
Tcg crossover management---1.01M
Blackrock---715.41K
Adage capital partners gp450.00K0.07%-650.00K
Commodore capital lp585.00K2.73%-590.00K

New Positions

HolderShares% AssetsChangeValue
Paradigm biocapital advisors lp961.16K2.62%961.16K$92.04M
Fred alger management502.88K0.19%502.88K$48.16M
Holocene advisors, lp487.23K0.11%487.23K$46.66M
Maverick capital417.55K0.53%417.55K$39.98M
Ubs oconnor315.47K8.12%315.47K$69.69M

Sold Out

HolderChange
Tortoise investment management-1.00
J.safra asset management-4.00
Sbi securities-9.00
Srs capital advisors-9.00
Principal securities-12.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202597-45.81%8,681,954-73.28%550.13%78-36.59%15-50.00%
Sep 30, 202556-53.72%4,347,245-83.22%270.10%41-58.16%928.57%
Jun 30, 2025121163.04%25,911,048172.67%1663.71%98262.96%7-22.22%
Mar 31, 20254720.51%9,559,38739.46%670.58%27-10.00%9200.00%
Dec 31, 20243944.44%6,854,593107.19%1074.21%30100.00%3-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv592.28K2.55%-13.13K
iShares Russell 2000 ETF404.28K1.59%-
Vanguard US Total Market Shares ETF121.55K1.11%-
abrdn Healthcare Investors179.90K0.71%-
Vanguard Institutional Extnd Mkt Idx Tr159.67K0.69%-69.89K
Fidelity Small Cap Index168.54K0.66%168.54K
iShares Russell 2000 Value ETF147.78K0.58%-
Fidelity Select Health Care140.00K0.55%140.00K
State St Russell Sm/Mid Cp® Indx SL Cl I93.02K0.42%72.02K
Invesco Dorsey Wright SmallCap Momt ETF104.73K0.41%136.00

Recent Insider Transactions

DateNameRoleActivityValue
Mar 31, 2017Stein Jeffrey President & CEOBuy$99.97K
Sep 12, 2017Stein Jeffrey President & CEOBuy$49.84K
Nov 10, 2020Stein Jeffrey President & CEOBuy$100.02K
Jun 05, 2017Stein Jeffrey President & CEOBuy$89.21K
Dec 10, 2025Ward Shane COO & CLOSell$2.19M

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q4-1
2025 Q3-1
2025 Q23-
2025 Q1-2

CDTX Ownership FAQ

Who Owns Cidara Therapeutics?

Cidara Therapeutics shareholders are primarily institutional investors at 55.84%, followed by 0.46% insiders and 43.70% retail investors. The average institutional ownership in Cidara Therapeutics's industry, Biotech Stocks , is 382.12%, which Cidara Therapeutics falls below.

Who owns the most shares of Cidara Therapeutics?

Cidara Therapeutics’s largest shareholders are Ra capital management (3.37M shares, 21.65%), Bain capital life sciences investors (3.02M shares, 19.43%), and Vanguard group (2.01M shares, 12.91%). Together, they hold 53.99% of Cidara Therapeutics’s total shares outstanding.

Does Blackrock own Cidara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cidara Therapeutics.

Who is Cidara Therapeutics’s biggest shareholder by percentage of total assets invested?

Bain capital life sciences investors is Cidara Therapeutics’s biggest shareholder by percentage of total assets invested, with 19.20% of its assets in 3.02M Cidara Therapeutics shares, valued at 289.29M$.

Who is the top mutual fund holder of Cidara Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cidara Therapeutics shares, with 2.55% of its total shares outstanding invested in 592.28K Cidara Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools